Biosynthetic pathway analysis of ginsenoiside Rh1 to notoginsenoside R2OA
Biosynthetic pathway analysis of ginsenoiside Rh1 to notoginsenoside R2
Rubing Wang;Yanan Zhang;Huanyu Zhang;Wenqi Yang;Yaowu Su;Hongyan Jing;Juan Wang;Wenyuan Gao
School of Pharmaceutical Science and Technology,Tianjin University,Tianjin 300072,China||State Key Laboratory of Synthetic Biology,Ministry of Education,Tianjin University,Tianjin 300072,ChinaSchool of Pharmaceutical Science and Technology,Tianjin University,Tianjin 300072,China||State Key Laboratory of Synthetic Biology,Ministry of Education,Tianjin University,Tianjin 300072,ChinaSchool of Pharmaceutical Science and Technology,Tianjin University,Tianjin 300072,China||State Key Laboratory of Synthetic Biology,Ministry of Education,Tianjin University,Tianjin 300072,ChinaSchool of Pharmaceutical Science and Technology,Tianjin University,Tianjin 300072,China||State Key Laboratory of Synthetic Biology,Ministry of Education,Tianjin University,Tianjin 300072,ChinaSchool of Pharmaceutical Science and Technology,Tianjin University,Tianjin 300072,China||State Key Laboratory of Synthetic Biology,Ministry of Education,Tianjin University,Tianjin 300072,ChinaSchool of Chinese Materia Medica,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,ChinaSchool of Pharmaceutical Science and Technology,Tianjin University,Tianjin 300072,China||State Key Laboratory of Synthetic Biology,Ministry of Education,Tianjin University,Tianjin 300072,ChinaSchool of Pharmaceutical Science and Technology,Tianjin University,Tianjin 300072,China||State Key Laboratory of Synthetic Biology,Ministry of Education,Tianjin University,Tianjin 300072,China
《中草药（英文版）》 2026 (2)
484-486,3
The authors gratefully acknowledge financial support from the ability establishment of sustainable use for valuable Chinese med-icine resources(No.2060302)and the Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences(No.CI2024C001YN).
评论